Ensuring Balance in National Policies on Controlled Substances
Guidance for Availability and Accessibility of Controlled Medicines (with CD-Rom)
Nonserial Publication
Technical Units
ISBN-13    9789241564175 ISBN-10    9241564172
Order Number    11500807 Format    Paper Back
Price    CHF    25.00 / US$    30.00 Developing countries:    CHF    17.50
English     2011        83   pages
Summary
Table of contents
Related Publications
Translation(s) available
Promotion flyer
 
 
   Add to your order
 
 
Summary
This book provides guidance on policies and legislation with regards to availability, accessibility, affordability and control of medicines made from substances regulated under the international drug control conventions, herein referred to as "controlled medicines". Their scope encompasses "all controlled medicines", but with a specific focus on essential medicines. Controlled medicines play an important role in several areas of medicine, including pain treatment, treatment of opioid dependence, emergency obstetrics, psychiatry and neurology.

The availability, accessibility and affordability of controlled medicines are important issues for all countries, but problematic for most of them. The World Health Organization (WHO) promotes governments, civil society and other interested individuals to strive for the maximum public health outcome of policies related to these medicines. WHO considers the public health outcome to be at its maximum (or "balanced") when the optimum is reached between maximizing access for rational medical use and minimizing substance abuse. Policy-makers, academia, civil society and other individuals whose area of work or interest is drug control or public health may potentially work with these guidelines in order to ensure that better use is made of controlled medicines and that more patients benefit from the advantages that their rational use can offer.